181 related articles for article (PubMed ID: 3040599)
1. Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals.
Seigneurin JM; Lavoue MF; Genoulaz O; Bornkamm GW; Lenoir GM
Int J Cancer; 1987 Sep; 40(3):349-53. PubMed ID: 3040599
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.
Rowe M; Finke J; Szigeti R; Klein G
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1217-28. PubMed ID: 2838572
[TBL] [Abstract][Full Text] [Related]
3. Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in nasopharyngeal carcinoma.
Chatani M; Teshima T; Inoue T; Yoshino K; Ikegami N; Hirai K; Shimakage M
Laryngoscope; 1991 Jun; 101(6 Pt 1):626-9. PubMed ID: 1645832
[TBL] [Abstract][Full Text] [Related]
4. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
Hewetson JF; Levine PH; Neubauer RH; Rabin H
Int J Cancer; 1982 Nov; 30(5):581-5. PubMed ID: 6295966
[TBL] [Abstract][Full Text] [Related]
5. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
6. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins.
Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R
J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523
[TBL] [Abstract][Full Text] [Related]
7. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6.
Lennette ET; Rymo L; Yadav M; Masucci G; Merk K; Timar L; Klein G
Eur J Cancer; 1993; 29A(11):1584-9. PubMed ID: 8217366
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
Henle G; Henle W
Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
[TBL] [Abstract][Full Text] [Related]
9. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis.
Mueller NE; Lennette ET; Dupnik K; Birmann BM
Int J Cancer; 2012 Jun; 130(12):2886-91. PubMed ID: 21805472
[TBL] [Abstract][Full Text] [Related]
10. [Strict correlation between anti-RANA antibodies and anti-EBNA antibodies apart from rheumatoid arthritis. Assessment of the diagnostic value of anti-RANA antibody].
Cohen JH; Lenoir GM; Colmet-Daage JF; Blanchard F; Etienne JC; Dropsy G; Gougeon J
Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):3-7. PubMed ID: 6302824
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
12. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and rheumatoid arthritis: are rheumatoid arthritis associated nuclear antigen and Epstein-Barr virus nuclear antigen different?
Cohen JH; Lenoir GM
Biomed Pharmacother; 1982; 36(5):246-9. PubMed ID: 6301567
[TBL] [Abstract][Full Text] [Related]
14. Detection of the EBV-determined nuclear antigen (EBNA) in Burkitt's lymphoma and nasopharyngeal carcinoma biopsies by the acid fixed nuclear binding (AFNB) technique.
Luka J; Klein G; Henle W; Henle G
Cancer Lett; 1978 Apr; 4(4):199-205. PubMed ID: 206349
[TBL] [Abstract][Full Text] [Related]
15. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
16. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
[TBL] [Abstract][Full Text] [Related]
17. Study of Epstein Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti-EA and Ig anti-EBNA obtained with an original microtiter technique: --serological criterions of primary and recurrent EBV infections and follow-up of infectious mononucleosis--seroepidemiology of EBV in Belgium based on 5178 sera from patients.
Lamy ME; Favart AM; Cornu C; Mendez M; Segas M; Burtonboy G
Acta Clin Belg; 1982; 37(5):281-98. PubMed ID: 6297194
[No Abstract] [Full Text] [Related]
18. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
Czeglédy J; Gergely L; Váczi L; Szalka A
Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.
Szigeti R; Kallin B; Dillner J; Henle G; Henle W; Lerner RA; Rymo L; Timar L; Klein G
Clin Immunol Immunopathol; 1989 Jun; 51(3):396-405. PubMed ID: 2470542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]